Mass spectrometry / NMR

#Bioseparation #Characterisation #Drug development #Drug discovery #LC-MS #Mass spectrometry / NMR

Isomer FOMO? Unlock hidden isomers in your LC-MS analysis

MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of complex molecules than traditional methods. Download the whitepaper “High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)” to learn more about:… Read More

#Resources

#Cell and protein analysis #Drug development #Drug discovery #Mass spectrometry / NMR #Regulatory

Podcast: Mass spectrometry advancing drug discovery

This is the latest episode of the free DDW narrated podcast, “How is mass spectrometry advancing drug discovery?”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Native mass spectrometry: Drug discovery’s new kid on the… Read More

#News

#Drug development #Drug discovery #Genetics / genomics #Mass spectrometry / NMR

The path to improved safety of gene-based products

Listen to this article on the DDW Podcast: Kerstin Pohl, Senior Global Marketing Manager, Gene Therapy & Nucleic Acid at SCIEX, looks at the application of liquid chromatography-mass spectrometry for analysing host cell proteins. Gene-based therapeutics and vaccines hold immense potential for more efficient and personalised treatment and prevention of complex… Read More

#Exclusive Content

#Drug discovery #Fragment-based drug discovery #Liquid chromatography #Mass spectrometry / NMR #SCIEX

How a recent advancement in mass spectrometry supports drug discovery

This paid-for advertorial by SCIEX appeared in DDW Volume 24 – Issue 2, Spring 2023 Imagine having the ability to consistently identify metabolic soft spots from an experiment that uses liquid chromatography coupled to mass spectrometry (LC-MS), reducing the need for additional safety testing in the drug discovery phase. Metabolite identification A… Read More

#Exclusive Content

Proteomics
#Genetics / genomics #Mass spectrometry / NMR #Nautilus #Oncology #Protein chemistry / Proteomics #Rare cancers

Democratising proteomics for cancer and beyond

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Nautilus Co-Founder and Chief Scientist Parag Mallick, about the company’s recent collaboration which aims to uncover the proteins that could be behind a rare and fatal childhood cancer. At the beginning of 2023, proteomics company Nautilus Biotechnology… Read More

#Exclusive Content #Trends & Analysis

#3D modelling #Biochemistry #CRISPR #DNA #Drug discovery #Gene editing #Genomics #Mass spectrometry / NMR #Screening

Podcast: Mass spectrometry and CRISPR

This is the latest episode of the free DDW podcast, “Mass spectrometry and CRISPR are pillars of drug discovery”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How ASMS offers more than seeing what sticks” and “… Read More

#News

Macrophage
#Cancer research #Immunology #Macomics #Mass spectrometry / NMR #Oncology #Transcriptomics #Tumour biology #Tumour microenvironment (TME)

Scottish company will target macrophages to treat cancer

Newly published discoveries have revealed possibilities for the treatment of cancer by targeting tumour-associated macrophages (TAMs) in the tumour microenvironment (TME).  The founding scientists behind Edinburgh-based Macomics, Dr Luca Cassetta and Professor Jeff Pollard, detail the seminal discoveries in macrophage biology over the past 50 years in… Read More

#Cancer Research #News

#Drug discovery #High throughput screening #Mass spectrometry / NMR

Transforming high-throughput screening with mass spectrometry

Arndt Asperger, Senior Applications Scientist, Bruker Daltonics and Meike Hamester, Vice President Label-Free Technologies, Bruker Daltonics, examine how challenges in mass spectrometry for high-throughput screening can be overcome using a label-free approach.   Mass spectrometry is inherently appealing for high-throughput screening (HTS), because it avoids certain drawbacks of label-based assays, but long-standing… Read More

#Exclusive Content

Liquid handler
#Automated liquid handling #Ionisation #Liquid chromatography #Mass spectrometry / NMR #Neuroinflammation

High throughput MALDI workflow with automated liquid handling

Download the new App Note from Analytik Jena to find out more about: The detection of lipid changes in microglia cells in generating therapeutic approach towards neuroinflammation diseases The application of label-free matrix-assisted laser desorption/ionisation (MALDI) MS cell fingerprinting workflows or cellular assays capable of characterising drug off-target responses with… Read More

#News

Team of scientists working in a lab
#Cell and protein analysis #Drug discovery #Mass spectrometry / NMR

Native mass spectrometry: Drug discovery’s new kid on the block

Listen to this article on the DDW Podcast: By Idlir Liko, Kleitos Sokratous & Miguel Silva at OMass Therapeutics Current drug discovery methods have limited success against certain drug targets and better approaches are needed. Professor Dame Carol Robinson’s work, including her recent publication in Nature, highlights how native mass spectrometry… Read More

#Exclusive Content

#C elegans #Ion mobility #Mass spectrometry / NMR #Metabolomics

IMS–MS potential for untargeted metabolomics

In this article, Professor Zheng-Zhu (Principal Investigator and Director of Metabolomics Research Center at the Shanghai Institute of Organic Chemistry) and Lucy Woods (Business Unit Manager for Phenomics and Metabolomics at Bruker Daltonics), summarise the most important configurations and options for partnering IMS–MS with liquid chromatography (LC) and show how… Read More

#Editor's Choice #Exclusive Content #News

#Mass spectrometry / NMR #Neurodegenerative disorders

Separating ganglioside isomers using HRIM–MS

In this article, Komal Kedia (Senior Scientist at Merck), Rena Zhang (Senior Scientist at Merck), Weixun Wang (Senior Scientist at Merck), Kevin Bateman (Scientific Associate VP at Merck) and Kelly Moser (Applications Manager at MOBILion Systems) show how ganglioside isomers with suspected roles in neurodegenerative diseases can be separated on… Read More

#Editor's Choice #Exclusive Content #News

#Biochemistry #Drug discovery #Mass spectrometry / NMR

How ASMS offers more than seeing what sticks 

Listen to this article on the DDW Podcast: Dr. Zack Gurard-Levin, Chief Scientific Officer, SAMDI Tech, breaks down three critical components to consider to ensure a successful affinity selection mass spectrometry (ASMS) drug discovery programme.  The ability to rapidly identify small molecules that non-covalently bind to a specific target is a critical… Read More

#Editor's Choice #Exclusive Content #News

#Assays #Mass spectrometry / NMR #Webinar

Webinar: Bioanalytical assay development using LC-MS/MS

A free webinar, Sensitive signature peptide quantification using accurate mass spectrometry, was hosted by DDW on December 1, 2021, at 4PM GMT, 9AM PT; 12PM ET; 5PM CET. It was supported by SCIEX.   Emerging advancements in protein biotherapeutics are driving the… Read More

#News

#Assays #Biotherapeutics #Drug targets #Mass spectrometry / NMR #Webinar

The challenges of peptide and protein quantification: Webinar

The importance of biotherapeutics as a class of drugs continues to increase. Indeed, their low toxicity and high specificity justify their investigation as drug candidates. Yet, quantification studies of biotherapies in complex biological matrices can be very challenging. In particular, high background noise and interferences due to endogenous proteins… Read More

#News

#Assays #Drug targets #Mass spectrometry / NMR #Webinar

The steps to developing a quantitative assay for signature peptides 

Sensitive signature peptide quantification using accurate mass spectrometry is a free webinar that was hosted by DDW on December 1, 2021, at 4PM GMT, 9AM PT; 12PM ET; 5PM CET. It was supported by SCIEX.  Dr. Xin Zhang, Senior Application Scientist at SCIEX, presented… Read More

#News